Shares of Advanced Micro Devices, Inc. (NASDAQ:AMD – Get Free Report) were up 0.9% on Thursday after an insider bought additional shares in the company. The stock traded as high as $114.60 and last ...

Outlook Therapeutics ( ($OTLK) ) has released its Q1 earnings. Here is a breakdown of the information Outlook Therapeutics presented to its ...

Elon Musk’s artificial intelligence company xAI is canvassing potential investors for a $10 billion funding round that would ...

AMD's new Ryzen AI Max+ 395 'Strix Halo' APU tested inside of new Mini-PC: up to 140W power at the ready, up to 128GB of ...

Synopsys, Inc. (Nasdaq: SNPS) today announced the expansion of its hardware-assisted verification (HAV) portfolio with new ...

The U.K.-headquartered chip design company Arm Holdings Plc. is reportedly planning to launch its first-ever complete ...

Supply issues with the Nvidia GeForce RTX 50 Series GPUs are expected to cause launch delays for the laptops they are supposed meant to power.

Nvidia's dominance and DeepSeek's rise could impact Advanced Micro Devices, Inc.'s stock price and growth potential. Click ...

Chip designer Arm plans to unveil its own processor this year with Meta as its launch customer. AMD says that it will not launch a 32GB version of the RX 9070 XT GPU, but that it will have an RX 9070 ...

Look at some companies that have a monopolistic place in the marketplace and decide whether it's a good idea to invest in them. The list is populated with some big names.

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...